TSLA

309.02

-0.22%↓

NKE

74.43

-0.6%↓

ORLY

102.26

+0.84%↑

HLT

260.19

-0.82%↓

AZO

4,012

+1.18%↑

TSLA

309.02

-0.22%↓

NKE

74.43

-0.6%↓

ORLY

102.26

+0.84%↑

HLT

260.19

-0.82%↓

AZO

4,012

+1.18%↑

TSLA

309.02

-0.22%↓

NKE

74.43

-0.6%↓

ORLY

102.26

+0.84%↑

HLT

260.19

-0.82%↓

AZO

4,012

+1.18%↑

TSLA

309.02

-0.22%↓

NKE

74.43

-0.6%↓

ORLY

102.26

+0.84%↑

HLT

260.19

-0.82%↓

AZO

4,012

+1.18%↑

TSLA

309.02

-0.22%↓

NKE

74.43

-0.6%↓

ORLY

102.26

+0.84%↑

HLT

260.19

-0.82%↓

AZO

4,012

+1.18%↑

Search

Allison Transmission Holdings Inc

Cerrado

SectorConsumo cíclico

85.79 -2.63

Resumen

Variación precio

24h

Actual

Mínimo

83.73

Máximo

88.11

Métricas clave

By Trading Economics

Ingresos

17M

192M

Ventas

-30M

766M

P/B

Media del Sector

10.348

35.993

BPA

2.253

Rentabilidad por dividendo

1.14

Margen de beneficio

25.065

Empleados

4,000

EBITDA

22M

284M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 meses

+9.1% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

1.14%

2.95%

Próximas Ganancias

28 oct 2025

Fecha Próximo Dividendo

29 ago 2025

Próxima Fecha de Ex Dividendo

18 ago 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-1.4B

7.5B

Apertura anterior

88.42

Cierre anterior

85.79

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

145 / 373 Clasificación en Consumer cyclical

Puntuación técnica

By Trading Central

Confianza

Weak Bullish Evidence

Allison Transmission Holdings Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

4 ago 2025, 21:42 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone

4 ago 2025, 21:21 UTC

Ganancias
Principales Movimientos del Mercado

Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update

4 ago 2025, 20:45 UTC

Ganancias

Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb

4 ago 2025, 19:15 UTC

Principales Movimientos del Mercado

TransMedics Group Shares Rise on FDA Approval for Clinical Trial

4 ago 2025, 23:41 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

4 ago 2025, 23:41 UTC

Charlas de Mercado

Nikkei May Rise on Fed Stimulus Hopes

4 ago 2025, 23:28 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

4 ago 2025, 23:28 UTC

Charlas de Mercado

Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk

4 ago 2025, 21:30 UTC

Ganancias

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4 ago 2025, 21:21 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com

4 ago 2025, 21:18 UTC

Ganancias

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4 ago 2025, 20:25 UTC

Charlas de Mercado

India Hits Back Over Russian Oil Purchases -- Market Talk

4 ago 2025, 20:25 UTC

Ganancias

Transocean 2Q Loss $938M >RIG

4 ago 2025, 20:25 UTC

Ganancias

Transocean 2Q Loss/Shr $1.06 >RIG

4 ago 2025, 20:18 UTC

Ganancias

Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com

4 ago 2025, 20:15 UTC

Ganancias

Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX

4 ago 2025, 20:14 UTC

Ganancias

Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX

4 ago 2025, 20:14 UTC

Ganancias

Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX

4 ago 2025, 20:14 UTC

Ganancias

Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX

4 ago 2025, 20:13 UTC

Ganancias

Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX

4 ago 2025, 20:09 UTC

Ganancias

Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM

4 ago 2025, 20:06 UTC

Ganancias

Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com

4 ago 2025, 20:01 UTC

Ganancias

Vertex Pharmaceuticals 2Q Net $1.03B >VRTX

4 ago 2025, 20:01 UTC

Ganancias

Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX

4 ago 2025, 20:01 UTC

Ganancias

Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX

4 ago 2025, 20:01 UTC

Ganancias

Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX

4 ago 2025, 19:41 UTC

Charlas de Mercado

U.S. Natural Gas Futures Settle Lower -- Market Talk

4 ago 2025, 19:28 UTC

Charlas de Mercado

U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk

4 ago 2025, 19:07 UTC

Charlas de Mercado

Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk

4 ago 2025, 18:27 UTC

Charlas de Mercado

Gold Climbs on Rate Cut Speculation -- Market Talk

Comparación entre iguales

Cambio de precio

Allison Transmission Holdings Inc Esperado

Precio Objetivo

By TipRanks

9.1% repunte

Estimación a 12 meses

Media 95.67 USD  9.1%

Máximo 105 USD

Mínimo 79 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Allison Transmission Holdings Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

6 ratings

1

Comprar

3

Mantener

2

Vender

Puntuación técnica

By Trading Central

92.39 / 99.11Soporte y Resistencia

Corto Plazo

Weak Bullish Evidence

Medio plazo

Weak Bearish Evidence

Largo Plazo

Weak Bearish Evidence

Sentimiento

By Acuity

145 / 373 Clasificación en Consumo cíclico

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Allison Transmission Holdings Inc

Allison Transmission Holdings, Inc., together with its subsidiaries, designs, manufactures, and sells fully automatic transmissions for medium- and heavy-duty commercial vehicles and medium- and heavy-tactical U.S. defense vehicles, and electrified propulsion systems worldwide. It provides commercial-duty on-highway, off-highway and defense fully automatic transmissions, and electric hybrid and fully electric systems. The company offers transmissions for various applications, including distribution, refuse, construction, fire, and emergency on-highway trucks; school and transit buses; motor homes; energy, mining, and construction off-highway vehicles and equipment; and wheeled and tracked defense vehicles. It provides its transmissions and electric propulsion solutions under the Allison Transmission brand name; and remanufactured transmissions under the ReTran brand name. The company also sells branded replacement parts, support equipment, aluminum die cast components, and other products necessary to service the installed base of vehicles utilizing its solutions, as well as defense kits, engineering services, and extended transmission coverage services to various original equipment manufacturers, distributors, and the U.S. government. It serves customers through an independent network of approximately 1,600 independent distributor and dealer locations. The company was formerly known as Clutch Holdings, Inc. Allison Transmission Holdings, Inc. was founded in 1915 and is headquartered in Indianapolis, Indiana.